Pharmacokinetics of Efavirenz and Treatment of HIV-1 Among Pregnant Women With and Without Tuberculosis Coinfection

BACKGROUND: Pregnancy and tuberculosis treatment or prophylaxis can affect efavirenz pharmacokinetics, maternal human immunodeficiency virus type 1 (HIV-1) treatment outcomes, and mother-to-child transmission (MTCT) risk. METHODS: We evaluated a prospective cohort of pregnant, HIV-infected women wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Dooley, Kelly E., Denti, Paolo, Martinson, Neil, Cohn, Silvia, Mashabela, Fildah, Hoffmann, Jennifer, Haas, David W., Hull, Jennifer, Msandiwa, Regina, Castel, Sandra, Wiesner, Lubbe, Chaisson, Richard E., McIlleron, Helen
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Major Articles and Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334832/
https://ncbi.nlm.nih.gov/pubmed/25081933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu429
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky